Drugs & Aging

, Volume 26, Issue 8, pp 687–701 | Cite as

Prescribing Optimization Method for Improving Prescribing in Elderly Patients Receiving Polypharmacy

Results of Application to Case Histories by General Practitioners
  • A. Clara Drenth-van Maanen
  • Rob J. van Marum
  • Wilma Knol
  • Carolien M. J. van der Linden
  • Paul A. F. JansenEmail author
Original Research Article



Optimizing polypharmacy is often difficult, and critical appraisal of medication use often leads to one or more changes. We developed the Prescribing Optimization Method (POM) to assist physicians, especially general practitioners (GPs), in their attempts to optimize polypharmacy in elderly patients. The POM is based on six questions: (i) is undertreatment present and addition of medication indicated; (ii) does the patient adhere to his/her medication schedule; (iii) which drug(s) can be withdrawn or which drugs(s) is/are inappropriate for the patient; (iv) which adverse effects are present; (v) which clinically relevant interactions are to be expected; and (vi) should the dose, dose frequency and/or form of the drug be adjusted?


The aim of this study was to evaluate the usefulness of the POM as a tool for improving appropriate prescribing of complex polypharmacy in the elderly.


Forty-five GPs were asked to optimize the medication of two case histories, randomly chosen from ten histories of geriatric patients admitted to a hospital geriatric outpatient clinic with a mean ± SD of 7.9±1.2 problems treated with 8.7±3.1 drugs. The first case was optimized without knowledge of the POM. After a 2-hour lecture on the POM, the GPs used the POM to optimize the medication of the second case history. The GPs were allowed 20 minutes for case optimization. Medication recommendations were compared with those made by an expert panel of four geriatricians specialized in clinical pharmacology. Data were analysed using a linear mixed effects model.


Optimization was significantly better when GPs used the POM. The proportion of correct decisions increased from 34.7% without the POM to 48.1% with the POM (p=0.0037), and the number of potentially harmful decisions decreased from a mean ±SD of 3.3±1.8 without the POM to 2.4±1.4 with the POM (p=0.0046).


The POM improves appropriate prescribing of complex polypharmacy in case histories.


Expert Panel Linear Mixed Effect Model Inappropriate Medication Medication List Acute Hospital Admission 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No sources of funding were used to assist in the conduct or preparation of this study. The authors have no conflicts of interest that are directly relevant to the content of this study. The authors would like to thank E.P. Martens, PhD, for his help with regard to the statistical analysis.


  1. 1.
    Stich ting Farmaceutische Kengetallen. Polyfarmacie. Pharm Weekblad 2005; 32: 968Google Scholar
  2. 2.
    Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57(1): 6–14PubMedCrossRefGoogle Scholar
  3. 3.
    Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005; 31: 4–11PubMedGoogle Scholar
  4. 4.
    Leendertse AJ, van den Bemt PMLA, Egberts ACG. Hospital admissions related to medication (HARM). Arch Int Med 2008; 168: 1890–6CrossRefGoogle Scholar
  5. 5.
    Bjorkman IK, Fastborn J, Schmidt IK, et al., the Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. The Pharmaceutical Care of the Elderly in Europe Research (PEER) Group: drug-drug interactions in the elderly. Ann Pharmacother 2002; 36: 1675–81PubMedCrossRefGoogle Scholar
  6. 6.
    Shi S, Mörike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008; 64(2): 183–99PubMedCrossRefGoogle Scholar
  7. 7.
    Kuijpers MAJ, van Marum RJ, Egberts ACG, et al., the OLDY (OLd people Drugs and dYsregulations) Study Group. Relationship between polypharmacy and under-prescribing. Br J Clin Pharmacol 2008 Jan; 65(1): 130–3PubMedCrossRefGoogle Scholar
  8. 8.
    Sloane PD, Gruber-Baldini AL, Zimmerman S, et al. Medication undertreatment in assisted living settings. Arch Intern Med 2004; 164(18): 1957–9CrossRefGoogle Scholar
  9. 9.
    Spinewine A, Schmader KE, Barber N, et al. Prescribing in elderly people: 1. Appropriate prescribing in elderly people: how well can it be measured and optimized? Lancet 2007; 370: 173–84PubMedCrossRefGoogle Scholar
  10. 10.
    Claxton AJ, Cramer J, Pierce C. A systematic review of the association between dose regimens and medication adherence. Clin Ther 2001; 23: 1296–310PubMedCrossRefGoogle Scholar
  11. 11.
    Kripalani S, Yao X, Haynes B. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007; 167: 540–50PubMedCrossRefGoogle Scholar
  12. 12.
    Kuzuya M, Endo H, Umegaki H, et al. Factors influencing nonadherence with medication regimens in the elderly. Nippon Ronen Igakkai Zasshi 2000; 37: 363–70PubMedCrossRefGoogle Scholar
  13. 13.
    Ryan AA. Medication adherence and older people: a review of the literature. Int J Nurs Stud 1999; 36: 153–62PubMedCrossRefGoogle Scholar
  14. 14.
    Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516–23PubMedCrossRefGoogle Scholar
  15. 15.
    Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825–32PubMedCrossRefGoogle Scholar
  16. 16.
    Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531–6PubMedCrossRefGoogle Scholar
  17. 17.
    Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24PubMedCrossRefGoogle Scholar
  18. 18.
    Wessel AM, Nietert PJ, Jenkins RG, et al. Inappropriate medication use in the elderly: results from a quality improvement project in 99 primary care practices. Am J Geriatr Pharmacother 2008; 6: 21–7CrossRefGoogle Scholar
  19. 19.
    Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45(10): 1045–51PubMedCrossRefGoogle Scholar
  20. 20.
    Barry PJ, Gallagher P, Ryan C, et al. START (Screening Tool to Alert doctors to the Right Treatment): an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 632–8PubMedCrossRefGoogle Scholar
  21. 21.
    Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to the Right Treatment): consensus validation. Int J Clin Pharmacol Ther 2008; 46(2): 72–83PubMedGoogle Scholar
  22. 22.
    Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004; 140(9): 714–20PubMedGoogle Scholar
  23. 23.
    Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2007; 65(3): 303–16PubMedCrossRefGoogle Scholar
  24. 24.
    Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116(6): 394–401PubMedCrossRefGoogle Scholar
  25. 25.
    Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized controlled trial. J Am Geriatr Soc 2007; 55(5): 658–65PubMedCrossRefGoogle Scholar
  26. 26.
    Nederlands Huisartsen Genootschap. NHG-standaarden [online]. Available from URL: [Accessed 2009 Jun 24]
  27. 27.
    Farmacotherapeutisch Kompas. College voor Zorgverzekeringen [online]. Available from URL: [Accessed 2009 Jun 24]
  28. 28.
    Wetenschappelijk Instituut Nederlandse Apothekers. Koninklijke Maatschappij ter bevordering van de Pharmacie Webrapportages farmacotherapie [online]. Available from URL: [Accessed 2009 Jun 24]
  29. 29.
    Centraal BegeleidingsOrgaan voor de intercollegiale toetsing. Kwaliteitsinstituut voor de gezondheidszorg. Richtlijnen [online]. Available from URL: [Accessed 2009 Jun 24]
  30. 30.
    Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074–90PubMedCrossRefGoogle Scholar
  31. 31.
    Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605–9PubMedCrossRefGoogle Scholar
  32. 32.
    Mannesse CK, Derkx FH, de Ridder MA, et al. Do older hospital patients recognize adverse drug reactions? Age Ageing 2000; 29(1): 79–81PubMedCrossRefGoogle Scholar
  33. 33.
    Naranjo CAA. Method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239–45PubMedCrossRefGoogle Scholar
  34. 34.
    Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly. Drug Safety 2007; 30(10): 911–8PubMedCrossRefGoogle Scholar
  35. 35.
    Indiana University Department of Medicine. Division of Clinical Pharmacology. Cytochrome P450 drug interaction table [online]. Available from URL: [Accessed 2009 Jun 24]
  36. 36.
    Rimon E, Kagansky N. Can creatinine clearance be accurately predicted by formulae in octogenarian in-patients? Q J Med 2004; 97: 281–7CrossRefGoogle Scholar
  37. 37.
    Fadem SZ. Cockroft Gault calculator [online]. Available from URL: [Accessed 2009 Jun 24]
  38. 38.
    Stevens LA, Coresh J, Greene T, et al. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473–83PubMedCrossRefGoogle Scholar
  39. 39.
    Hanlon JT, Aspinall SL, Semla TP, et al. Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc 2009; 57(2): 335–40PubMedCrossRefGoogle Scholar
  40. 40.
    Koninklijke Nederlandse Maatschappij ter bevordering van de Pharmacie. Kennisbank. G-standaard verminderde nierfunctie. Tabel bij ‘Verminderde nierfunctie. Doseringsadviezen voor geneesmiddelen’ [online]. Available from URL: [Accessed 2009 Jun 24]

Copyright information

© Adis Data Information BV 2009

Authors and Affiliations

  • A. Clara Drenth-van Maanen
    • 1
  • Rob J. van Marum
    • 1
  • Wilma Knol
    • 1
  • Carolien M. J. van der Linden
    • 2
  • Paul A. F. Jansen
    • 1
    Email author
  1. 1.Department of Geriatric MedicineUniversity Medical CentreUtrechtthe Netherlands
  2. 2.Department of Geriatric MedicineCatharina HospitalEindhoventhe Netherlands

Personalised recommendations